Patent ID: 7897589

Claim:
A substituted pyrazoline compound of formula I, wherein R 1 represents a phenyl radical that is substituted with a hydroxy, fluorine, chlorine, bromine or iodine atom or a —O—CH 3 -group in the para-(4-)-position of the phenyl radical; R 2 represents a (2,4)-dichloro-phenyl radical; R 3 represents a —NR 4 R 5 moiety; R 4 represents a hydrogen atom; R 5 represents a radical selected from the group consisting of adamantyl, bicyclo[2.2.1]heptyl, bicyclo[3.1.1]heptyl, (1,7,7)-trimethyl-bicyclo[2.2.1]heptyl, [1,2,3,4]-tetrahydronaphthyl, cyclononyl, cyclodecyl, cycloundecyl and cyclododecyl; a radical selected from the group consisting of cyclopropyl, cyclobutyl, cyclopentyl, cyclohexyl, cycloheptyl, cyclooctyl, pyrrolidinyl, piperidinyl, piperazinyl, homopiperazinyl, morpholinyl, azepanyl, diazepanyl and azocanyl, which is bonded via a —(CF 2 )—, —(CH 2 )—CH 2 )— or —(CH 2 )—(CH 2 )—(CH 2 )-group; a substituted radical selected from the group consisting of cyclopentyl, cyclohexyl and cyloheptyl which is substituted with a —O-Benzyl radical; or a radical selected from the group consisting of which is in each case bonded to the pyrazoline compound of formula I in any position of the cyclic part of the aforementioned radicals including the NH-groups; optionally in a form of one of its stereoisomers or a racemate or in a form of a mixture of at least two of its stereoisomers in any mixing ratio, or a corresponding N-oxide thereof, or a physiologically acceptable salt thereof.